ACCURAY INC — Form 8-K
Filed October 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 78/100
What the filing says
Accuray stockholders approved financing with TCW Asset Management (primary lender, largest shareholder) on October 6, 2026: $40M term loan debt converted to convertible preferred stock, $15M new equity investment, up to $5M delayed draw term loan, covenant relief through end-2027, and reverse stock split (1-for-15 to 1-for-40 ratio, board discretion). Also appointed healthcare veteran Randy Meier to board. These transactions provide liquidity runway and financial flexibility.
Why this rating
$55M financing (63% of $86.9M market cap) is material; refinancing existing debt reduces burn but signals financial stress. Reverse split typically negative signal despite operational benefits. Governance addition positive.
Price action (we called it neutral)
before filing · preread $0.26 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.